Literature DB >> 18395914

Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis.

Xiao-Ling Wu1, Wei-Zheng Zeng, Ming-De Jiang, Jian-Ping Qin, Hui Xu.   

Abstract

AIM: To explore the anti-fibrotic effect of Oxymatrine on CCl4-induced liver fibrosis in rats and its modulation on the TGFbeta-Smad signaling pathway.
METHODS: One hundred healthy male SD rats were randomly divided into three groups: normal group (n = 20), treatment group of Oxymatrine (n = 40) and CCl4-induced fibrosis group (n = 40). Experimental hepatic fibrosis was induced by subcutaneous injection of carbon tetrachloride (CCl4 soluted in liquid paraffin with the concentration of 300 g/L, the dosage of injection was 3 mL/kg, twice per week for 8 wk). The treated rats received Oxymatrine via celiac injection at a dosage of 10 mg/kg twice a week at the same time. The deposition of collagen was observed with H&E and Masson staining. The concentration of serum TGF-beta1 was assayed with ELISA. The gene expression of Smads and CBP (CREB binding protein) was detected with in situ hybridization (ISH) and immunohistochemistry (IH), respectively. All the experimental figures were scanned and analyzed with special figure-analysis software.
RESULTS: A significant reduction of collagen deposition and rearrangement of the parenchyma was noted in the liver tissue of Oxymatrine-treated rats. The semiquantitative histological scores (2.43 +/- 0.47 microm2 vs 3.76 +/- 0.68 microm2, P < 0.05) and average area of collagen in those rats were significantly decreased when compared with hepatic cirrhosis model rats (94.41 +/- 37.26 microm2 vs 290.86 +/- 89.37 microm2, P < 0.05). The gene expression of Smad 3 mRNA was considerably decreased in the treated animals. The A value of Smad 3 mRNA was lower in the treated rats than the model rats (0.034 +/- 0.090 vs 0.167 +/- 0.092, P < 0.05). Contrarily, the A value of Smad 7 mRNA was increased considerably in the treated animals (0.175 +/- 0.065 vs 0.074 +/- 0.012, P < 0.05). There was an obvious decrease in the expression of CBP mRNA in treated rats as illuminated by a reduction of its A value when compared with model rats (0.065 +/- 0.049 vs 0.235 +/- 0.025, P < 0.001).
CONCLUSION: Oxymatrine is effective in reducing the production and deposition of collagen in the liver tissue of experimental rats. Oxymatrine could promote the expression of Smad 7 and inhibit the expression of Smad 3 and CBP in CCl4-induced hepatic fibrosis in SD rats, could modulate the fibrogenic signal transduction of TGFbeta-Smad pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395914      PMCID: PMC2701534          DOI: 10.3748/wjg.14.2100

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms.

Authors:  Xiao-Ling Wu; Wei-Zheng Zeng; Pi-Long Wang; Chun-Tao Lei; Ming-De Jiang; Xiao-Bin Chen; Yong Zhang; Hui Xu; Zhao Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury.

Authors:  Yoshiya Tahashi; Koichi Matsuzaki; Masataka Date; Katsunori Yoshida; Fukiko Furukawa; Yasushi Sugano; Masanori Matsushita; Yasuo Himeno; Yutaka Inagaki; Kyoichi Inoue
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

3.  [Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial].

Authors:  Lun-gen Lu; Min-de Zeng; Yi-min Mao; Mo-bin Wan; Cheng-zhong Li; Cheng-wei Chen; Qing-chun Fu; Ji-yao Wang; Wei-min She; Xiong Cai; Jun Ye; Xia-qui Zhou; Hiu Wang; Shan-ming Wu; Mei-fang Tang; Jin-shui Zhu; Wei-xiong Chen
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2004-10

Review 4.  Antifibrotic therapy in chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Gastroenterol Hepatol       Date:  2005-02       Impact factor: 11.382

Review 5.  Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis.

Authors:  Franck Verrecchia; Alain Mauviel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 6.  TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.

Authors:  Meinhard Schiller; Delphine Javelaud; Alain Mauviel
Journal:  J Dermatol Sci       Date:  2004-08       Impact factor: 4.563

7.  [The effects of Chinese national medicine of Huoxueruanjian compound on SMAD signal in hepatic stellate cell and its significance].

Authors:  Guo Zhang; Fa-can Zhang; Tian-cai Wang; Kuo-huan Liang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2004-04

Review 8.  Modulation of liver injury by interleukin-10.

Authors:  H Louis; O Le Moine; M Goldman; J Devière
Journal:  Acta Gastroenterol Belg       Date:  2003 Jan-Mar       Impact factor: 1.316

Review 9.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

Review 10.  On and off: proteasome and TGF-beta signaling.

Authors:  Fan Zhang; Marikki Laiho
Journal:  Exp Cell Res       Date:  2003-12-10       Impact factor: 3.905

View more
  18 in total

1.  Protective effect of Oxymatrine against acute spinal cord injury in rats via modulating oxidative stress, inflammation and apoptosis.

Authors:  Binggang Guan; Rongchun Chen; Mingliang Zhong; Ning Liu; Qin Chen
Journal:  Metab Brain Dis       Date:  2019-12-15       Impact factor: 3.584

2.  Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats.

Authors:  Yi-cheng Jian; Wei Li; Yi He; Ming Jiang; Yan-bing Liu; Wu-jun Xiong
Journal:  Chin J Integr Med       Date:  2012-07-22       Impact factor: 1.978

3.  Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity.

Authors:  Jun Zhou; De-Wu Zhong; Qun-Wei Wang; Xiong-Ying Miao; Xun-Di Xu
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

Review 4.  Nanotechnology applications for the therapy of liver fibrosis.

Authors:  Lydia Giannitrapani; Maurizio Soresi; Maria Luisa Bondì; Giuseppe Montalto; Melchiorre Cervello
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.

Authors:  Ning-Li Chai; Qiang Fu; Hui Shi; Chang-Hao Cai; Jun Wan; Shi-Ping Xu; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

6.  Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-β1/Smads signaling pathway.

Authors:  Zongtao Hu; Feng Qin; Shile Gao; Yilan Zhen; Dake Huang; Liuyi Dong
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

Review 7.  The expression of Smad signaling pathway in myocardium and potential therapeutic effects.

Authors:  Yuping Duan; Wei Zhu; Min Liu; Muhammad Ashraf; Meifeng Xu
Journal:  Histol Histopathol       Date:  2016-11-15       Impact factor: 2.303

8.  Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis.

Authors:  Christoph Roderburg; Tobias Mollnow; Brenda Bongaerts; Natalia Elfimova; David Vargas Cardenas; Katharina Berger; Henning Zimmermann; Alexander Koch; Mihael Vucur; Mark Luedde; Claus Hellerbrand; Margarete Odenthal; Christian Trautwein; Frank Tacke; Tom Luedde
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

9.  Predicting in vivo anti-hepatofibrotic drug efficacy based on in vitro high-content analysis.

Authors:  Baixue Zheng; Looling Tan; Xuejun Mo; Weimiao Yu; Yan Wang; Lisa Tucker-Kellogg; Roy E Welsch; Peter T C So; Hanry Yu
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

10.  Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.

Authors:  Lirong Liu; Yuanyuan Wang; Rui Yan; Shuang Li; Mingjun Shi; Ying Xiao; Bing Guo
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.